Calculate the mass, volume, or concentration required for a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
A126525-20mg | 20mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $46.90 | |
A126525-50mg | 50mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $96.90 | |
A126525-250mg | 250mg | In stock | $436.90 | |
A126525-1g | 1g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,571.90 |
JAK2/3 inhibitor
Synonyms | 133550-30-8|AG-490|Tyrphostin B42|AG 490|Tyrphostin AG 490|(E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide|AG490|Tyrphostin AG490|N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide|134036-52-5|(E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enam |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Dry ice |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of epidermal growth factor receptor |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488195367 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488195367 |
IUPAC Name | (E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide |
INCHI | InChI=1S/C17H14N2O3/c18-10-14(8-13-6-7-15(20)16(21)9-13)17(22)19-11-12-4-2-1-3-5-12/h1-9,20-21H,11H2,(H,19,22)/b14-8+ |
InChi Key | TUCIOBMMDDOEMM-RIYZIHGNSA-N |
Canonical SMILES | C1=CC=C(C=C1)CNC(=O)C(=CC2=CC(=C(C=C2)O)O)C#N |
Isomeric SMILES | C1=CC=C(C=C1)CNC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N |
WGK Germany | 3 |
PubChem CID | 5328779 |
Molecular Weight | 294.3 |
PubChem CID | 5328779 |
---|---|
CAS Registry No. | 133550-30-8 |
ChEMBL Ligand | CHEMBL56543 |
PubChem SID | 488195367 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
Certificate of Analysis | Mar 22, 2023 | A126525 | |
Certificate of Analysis | Mar 17, 2023 | A126525 | |
Certificate of Analysis | Jan 13, 2023 | A126525 |
Solubility | DMSO ≥57mg/mL Water <1.2mg/mL Ethanol ≥8mg/mL |
---|---|
Sensitivity | Light Sensitive,Air Sensitive,Heat Sensitive |
Melt Point(°C) | 215°C |
Pictogram(s) | GHS06,GHS09 |
---|---|
Signal | Danger |
Hazard Statements | H301,H400 |
Precautionary Statements | P273,P321,P405,P501,P264,P270,P391,P330,P301+P316 |
WGK Germany | 3 |
1. Gazit A, Osherov N, Posner I, Yaish P, Poradosu E, Gilon C, Levitzki A. (1991) Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases.. J Med Chem, 34 (6): (1896-907). [PMID:1676428] |
2. Zeng Y et al.. (2014) Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.. Carcinogenesis, 35 (10): (2244-53). [PMID:24925029] |
3. Zhang Z et al.. (2021) Neuritin inhibits astrogliosis to ameliorate diabetic cognitive dysfunction.. J Mol Endocrinol, 66 (4): (259-272). [PMID:33729996] |
4. Wang Y & Li Y. (2018) MiR-29c inhibits HCV replication via activation of type I IFN response by targeting STAT3 in JFH-1-infected Huh7 cells.. RSC Adv, 8 (15): (8164-8172). [PMID:35542013] |
5. Li HN et al.. (2021) Red nucleus IL-33 facilitates the early development of mononeuropathic pain in male rats by inducing TNF-a through activating ERK, p38 MAPK, and JAK2/STAT3.. J Neuroinflammation, 18 (150). [PMID:34225736] |
6. Guo YJ et al.. (2018) Red nucleus interleukin-1ß evokes tactile allodynia through activation of JAK/STAT3 and JNK signaling pathways.. J Neurosci Res, 96 (12): (1847-1861). [PMID:30216497] |